Evidence that AMP-activated protein kinase can negatively modulate Ornithine decarboxylase activity in cardiac myoblasts

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 4, 2012, Pages 800-807

  Passariello, Catherine L ^a   Gottardi, Davide ^a   Cetrullo, Silvia ^a   Zini, Maddalena ^a   Campana, Gabriele ^a   Tantini, Benedetta ^a   Pignatti, Carla ^a   Flamigni, Flavio ^a   Guarnieri, Carlo ^a   Caldarera, Claudio M ^b   Stefanelli, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b National Institute for Cardiovascular Research INRC   (Italy)

Author keywords

AMP activated protein kinase (AMPK); Cardiac hypertrophy; Isoproterenol; Ornithine decarboxylase (ODC)

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOPRENALINE; ORNITHINE DECARBOXYLASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYAMINE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARDIOMEGALY; DOWN-REGULATION; EFLORNITHINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; ISOPROTERENOL; MYOBLASTS, CARDIAC; ORNITHINE DECARBOXYLASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84857410595     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.12.013     Document Type: Article

References (57)

1. Gradman A.H., Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog. Cardiovasc. Dis. 2006, 48:326-341.
2. Taegtmeyer H., Sen S., Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. N. Y. Acad. Sci. 2010, 1188:191-198.
3. Giordano E., Flamigni F., Guarnieri C., Muscari C., Pignatti C., Stefanelli C., Tantini B., Caldarera C.M. Polyamines in cardiac physiology and disease. Open Heart Fail. J. 2010, 3:25-30.
4. Bartolome J., Huguenard J., Slotkin T.A. Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science (Washington, D.C.) 1980, 210:793-794.
5. Cubria J.C., Reguera R., Balana-Fouce R., Ordonez C., Ordonez D. Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. J. Pharm. Pharmacol. 1998, 50:91-96.
6. Schlüter K.D., Frischkopf K., Flesch M., Rosenkranz S., Taimor G., Piper H.M. Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy. Cardiovasc. Res. 2000, 45:410-417.
7. Schäfer M., Frischkopf K., Taimor G., Piper H.M., Schlüter K.D. Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomiopatia from adult rat. Am. J. Physiol. Cell Physiol. 2000, 279:C495-C503.
8. Cetrullo S., Facchini A., Stanic I., Tantini B., Pignatti C., Caldarera C.M., Flamigni F. Difluoromethylornithine inhibits hypertrophic, pro-fibrotic and pro-apoptotic actions of aldosterone in cardiac cells. Amino Acids 2010, 38:525-531.
9. Shantz L.M., Feith D.J., Pegg A.E. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem. J. 2001, 358:25-32.
10. Mörlein C., Schreckenberg R., Schlüter K.D. Ornithine decarboxylase activity modifies apoptotic and hypertrophic marker expression in post-ischemic hearts. Open Heart Fail. J. 2010, 3:31-36.
11. Pegg A.E. Effect of α-difluoromethylornithine on cardiac polyamine content and hypertrophy. J. Mol. Cell. Cardiol. 1981, 13:881-887.
12. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
13. Wong A.K.F., Howie J., Petrie J.R., Lang C.C. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin. Sci. (Lond) 2009, 116:607-620.
14. Kim A.S., Miller E.J., Young L.H. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol. 2009, 196:37-53.
15. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W.S., Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 2004, 10:1384-1389.
16. Zarrinpashneh E., Beauloye C., Ginion A., Pouleur A.C., Havaux X., Hue L., Viollet B., Vanoverschelde J.L., Bertrand L. AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol. Biochem. Biophys. Res. Commun. 2008, 376:677-681.
17. Chan A.Y., Dyck J.R. Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy. Can. J. Physiol. Pharmacol. 2005, 83:24-28.
18. Arad M., Seidman C.E., Seidman J.G. AMP-activated protein kinase in the heart. Role during health and disease. Circ. Res. 2007, 100:474-488.
19. Allard M.F., Parsons H.L., Saeedi R., Wambolt R.B., Brownsey R. AMPK and metabolic adaptation by the heart to pressure overload. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H140-H148.
20. Nascimben L., Ingwall J.S., Lorell B.H., Pinz I., Schultz V., Tornheim K., Tian R. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 2004, 44:662-667.
21. Saeedi R., Saran V.V., Wu S.S.Y., Kume E.S., Paulson K., Chan A.P.K., Parsons H.L., Wambolt R.B., Dyck J.R.B., Brownsey R.W., Allard M.F. AMP-activated protein kinase influences metabolic remodeling in H9c2 cells hypertrophied by arginine vasopressin. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1822-H1832.
22. An D., Kewalramani G., Qi D., Pulinilkunnil T., Ghosh S., Abrahani A., Wambolt R., Allard M., Innis S.M., Rodrigues B. β-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1120-E1127.
23. Xu M., Zhao Y.T., Song Y., Hao T.P., Lu Z.Z., Han Q.D., Wang S.Q., Zhang Y.Y. α1-adrenergic receptors activate AMP-activated protein kinase in rat hearts. Acta Physiol. Sin. 2007, 59:175-182.
24. Jaswal J.S., Lund C.R., Keung W., Beker D.L., Rebeyka I.M., Lopaschuk G.D. Isoproterenol stimulates 5'-AMP-activated protein kinase and fatty acid oxidation in neonatal hearts. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1135-H1145.
25. Cetrullo S., Tantini B., Facchini A., Pignatti C., Stefanelli C., Caldarera C.M., Flamigni F. A pro-survival effect of polyamine depletion on norepinephrine-mediated apoptosis in cardiac cells: role of signaling enzymes. Amino Acids 2011, 40:1127-1137.
26. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxf) 2009, 196:65-80.
27. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell. Dev. Biol. Anim. 2011, 47:125-131.
28. Tantini B., Fiumana E., Cetrullo S., Pignatti C., Bonavita F., Shantz L.M., Giordano E., Muscari C., Flamigni F., Guarnieri C., Stefanelli C., Caldarera C.M. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. J. Mol. Cell. Cardiol. 2006, 40:775-782.
29. Noble J.E., Bailey M.J.A. Quantitation of protein. Methods Enzymol. 2009, 463:73-95.
30. Flamigni F., Facchini A., Capanni C., Stefanelli C., Tantini B., Caldarera C.M. p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem. J. 1999, 341:363-369.
31. i homeostasis and contractility in isolated rat ventricular cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 1994, 267:H587-H592.
32. Lazarowski E.R., Tarran R., Grubb B.R., van Heusden C.A., Okada S., Boucher R.C. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J. Biol. Chem. 2004, 279:36855-36864.
33. Villeneuve C., Caudrillier A., Ordener C., Pizzinat N., Parini A., Mialet-Perez J. Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H821-H828.
34. Hwang G.S., Oh K.S., Koo H.N., Seo H.W., You K.H., Lee B.H. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. Eur. J. Pharmacol. 2006, 540:131-138.
35. Jeong K., Kwon H., Min C., Pak Y. Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts. Exp. Mol. Med. 2009, 41:226-235.
36. Passariello C.L., Zini M., Nassi P.A., Pignatti C., Stefanelli C. Upregulation of SIRT1 deacetylase in phenylephrine-treated cardiomyoblasts. Biochem. Biophys. Res. Commun. 2011, 407:512-516.
37. Pegg A.E. Regulation of ornithine decarboxylase. J. Biol. Chem. 2006, 281:14529-14532.
38. Henin N., Vincent M.F., Van den Berghe G. Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim. Biophys. Acta 1996, 197:197-203.
39. Al-Khalili L., Chibalin A.V., Yu M., Sjödin B., Nylén C., Zierath J.R., Krook A. MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am. J. Physiol. Cell Physiol. 2004, 286:C1410-C1416.
40. Bain J., Plater L., Elliott M., Shapiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
41. Rose B.A., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 2010, 90:1507-1546.
42. Clerk A., Sugden P.H. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am. J. Cardiol. 1999, 83:64H-69H.
43. Thornton C., Sardini A., Carling D. Muscarinic receptor activation of AMP-activated protein kinase inhibits orexigenic neuropeptide mRNA expression. J. Biol. Chem. 2008, 283:17116-17122.
44. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 2010, 1804:581-591.
45. Yin W., Mu J., Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J. Biol. Chem. 2003, 278:43074-43080.
46. Hutchinson D.S., Chernogubova E., Dallner O.S., Cannon B., Bengtsson T. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005, 48:2386-2395.
47. Joubert R., Métayer Coustard S., Swennen Q., Sibut V., Crochet S., Cailleau-Audouin E., Buyse J., Decuypere E., Wrutniak-Cabello C., Cabello G., Tesseraud S., Collin A. The beta-adrenergic system is involved in the regulation of the expression of avian uncoupling protein in the chicken. Domest. Anim. Endocrinol. 2010, 38:115-125.
48. Boone A.N., Rodrigues B., Brownsey R.W. Multiple-site phosphorylation of the 280kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of beta-adrenergic stimulation. Biochem. J. 1999, 341:347-354.
49. Pulinilkunnil T., He H., Kong D., Asakura K., Peroni O.D., Lee A., Kahn B.B. Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. J. Biol. Chem. 2011, 286:8798-8809.
50. Tsuchiya Y., Denison F.C., Heath R., Carling D., Saggerson D. 5'-AMP-activated protein kinase is inactivated by adrenergic signalling in adult cardiac myocytes. Biosci. Rep. 2012, 32:197-209.
51. Gerner E.W., Meyskens F.L. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 2004, 4:781-792.
52. Flamigni F., Marmiroli S., Capanni C., Stefanelli C., Guarnieri C., Caldarera C.M. Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth. Biochem. Biophys. Res. Commun. 1997, 239:729-733.
53. Kimball S.R., Shantz L.M., Horetsky R.L., Jefferson L.S. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 1999, 274:11647-11652.
54. Shantz L.M. Transcriptional and translational control of ornithine decarboxylase during Ras transformation. Biochem. J. 2004, 377:257-264.
55. Simm A., Schlüter K., Diez C., Piper H.M., Hoppe J. Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J. Mol. Cell. Cardiol. 1998, 30:2059-2067.
56. Morisco C., Zebrowski D., Condorelli G., Tsichlis P., Vatner S.F., Sadoshima J. The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 2000, 275:14466-14475.
57. Yano N., Ianus V., Zhao T.C., Tseng A., Padbury J.F., Tseng Y.T. A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H385-H393.